Significant Ownership of James E. Flynn
- Signature - Title
- /s/ Jonathan Isler - Jonathan Isler, Attorney-in-Fact
- Location
- New York, NY
- Summary
- This page shows a list of all the recent SCHEDULE 13D/G filings made by James E. Flynn.
Follow Filing Activity
Follow James E. Flynn and return when a new Schedule 13D/G filing changes the record on this page.
This uses the existing product follow flow to surface future filing-backed changes without guessing what they mean. If you create an account from here, we will bring you back after verification.
Useful next steps after a schedule filing
Use the page below that answers the next obvious question about this reporting manager or security.
- Latest 13D/G reports to compare this manager with other current ownership disclosures.
- Latest insider ownership reports if you want insider activity alongside the beneficial ownership record.
- Latest 13F portfolio filings for broader institutional context.
- Latest investment quarter holder pages when the next step is security-level holder history.
Significant Ownership of James E. Flynn
| Sym | Company | Class | Ownership | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|---|
| OMIC | Singular Genomics Systems, Inc. | Common Stock, par value $0.0001 per share | 100% | $20,010 | -$4,972,385 | 1,000 | -100% | Deerfield Mgmt IV, L.P. | 21 Feb 2025 |
| LRMR | Larimar Therapeutics, Inc. | Common Stock, par value $0.01 per share | 34% | $123,052,785 | +$17,250,000 | 35,667,474 | +16% | Deerfield Management Company, L.P. | 27 Feb 2026 |
| NUVL | Nuvalent, Inc. | Class A common stock, $0.0001 par value per share | 24% | $2,238,152,303 | -$71,496,004 | 22,852,280 | -3.1% | Deerfield Management Company, L.P. | 31 Dec 2025 |
| PHGE | BiomX Inc. | Common Stock, par value $0.0001 per share | 10% | $2,245,157 | 989,056 | Deerfield Management Company, L.P. | 09 Feb 2026 | ||
| PHGE | BiomX Inc. | Common Stock, par value $0.0001 per share | 10% | 989,056 | -94% | Deerfield Management Company, L.P. | 15 Apr 2026 | ||
| AFIB | Acutus Medical, Inc. | Common Stock, par value $0.001 per share | 9.1% | $233,441 | -$179,058 | 5,492,725 | -43% | James E. Flynn | 27 Jan 2025 |
| FHTX | Foghorn Therapeutics Inc. | Common Stock | 8.6% | $24,566,920 | 5,139,523 | Deerfield Mgmt, L.P. | 31 Mar 2026 | ||
| AHCO | AdaptHealth Corp. | Class A Common Stock | 8.5% | $213,579,981 | 23,863,685 | Deerfield Management Company, L.P. | 30 Sep 2025 | ||
| Lomond Therapeutics Holdings, Inc. | Common Stock | 8.4% | 2,692,625 | Deerfield Mgmt, L.P. | 30 Sep 2025 | ||||
| SPRY | ARS Pharmaceuticals, Inc. | Common Stock, par value $0.0001 per share | 7.8% | $134,624,739 | -$18,102,531 | 7,610,217 | -12% | Deerfield Management Company, L.P. | 30 Jul 2025 |
| BCRX | BioCryst Pharmaceuticals, Inc. | Common Stock | 6.8% | $109,278,420 | +$16,550,640 | 14,341,000 | +18% | Deerfield Mgmt, L.P. | 31 Dec 2025 |
| SVRA | Savara Inc. | Common Stock | 6.7% | $48,441,330 | 13,569,000 | Deerfield Mgmt, L.P. | 30 Oct 2025 | ||
| HLXB | BridgeBio Oncology Therapeutics, Inc. | Common Stock | 6.2% | 4,885,446 | Deerfield Management Company, L.P. | 11 Aug 2025 | |||
| COGT | Cogent Biosciences, Inc. | Common Stock | 5.3% | $348,099,826 | -$354,685 | 9,043,903 | -0.1% | Deerfield Mgmt, L.P. | 31 Mar 2026 |
| VERA | Vera Therapeutics, Inc. | Common Stock | 5.2% | $75,299,151 | 3,348,117 | Deerfield Mgmt, L.P. | 06 Jun 2025 | ||
| CGEM | Cullinan Therapeutics, Inc. | Common Stock | 5% | $17,357,187 | 2,927,013 | Deerfield Mgmt, L.P. | 30 Sep 2025 | ||
| DCGO | DocGo Inc. | Common Stock | 5% | $11,214,330 | 5,051,500 | Deerfield Mgmt, L.P. | 13 Feb 2025 | ||
| BKD | Brookdale Senior Living Inc. | Common Stock | 4.9% | $89,721,517 | -$28,721,539 | 11,637,032 | -24% | Deerfield Mgmt, L.P. | 22 Aug 2025 |
| CERT | Certara, Inc. | Common Stock | 4.9% | $88,705,753 | -$25,019,207 | 7,808,605 | -22% | Deerfield Mgmt, L.P. | 25 Nov 2025 |
| EMBC | Embecta Corp. | Common Stock | 4.7% | $32,319,956 | 2,720,535 | Deerfield Mgmt, L.P. | 31 Mar 2025 | ||
| INSP | Inspire Medical Systems, Inc. | Common Stock | 4.5% | $70,212,109 | -$9,714,936 | 1,296,862 | -12% | Deerfield Mgmt, L.P. | 14 May 2026 |
| CALC | CalciMedica Inc. | Common Stock | 4.3% | $4,304,937 | 653,253 | Deerfield Mgmt, L.P. | 06 Feb 2026 | ||
| MNKTQ | Mallinckrodt plc | Ordinary Shares, par value $0.01 per share | 4.1% | 804,259 | Deerfield Management Company, L.P. | 31 Mar 2025 | |||
| ALHC | Alignment Healthcare, Inc. | Common Stock | 3.8% | $129,213,102 | 7,304,302 | Deerfield Mgmt, L.P. | 31 Dec 2024 | ||
| INDV | Indivior PLC | Ordinary Shares, $0.50 nominal value per share | 3.7% | $111,255,547 | -$143,518,681 | 4,614,498 | -56% | Deerfield Mgmt, L.P. | 10 Nov 2025 |
| CPRX | Catalyst Pharmaceuticals, Inc. | Common Stock | 2.6% | $74,033,050 | 3,133,011 | Deerfield Mgmt, L.P. | 31 Dec 2024 | ||
| VTYX | Ventyx Biosciences, Inc. | Common Stock | 0.76% | $673,769 | 534,737 | Deerfield Mgmt, L.P. | 31 Dec 2024 | ||
| OSCR | Oscar Health, Inc. | Class A Common Stock | 0% | $0 | 0 | Deerfield Mgmt, L.P. | 30 Sep 2025 | ||
| OMI | Owens & Minor, Inc. | Common Stock | 0% | $0 | 0 | Deerfield Mgmt, L.P. | 31 Mar 2025 | ||
| PRLD | Prelude Therapeutics Incorporated | Common Stock | 0% | $0 | 0 | Deerfield Mgmt, L.P. | 31 Dec 2024 | ||
| KURA | Kura Oncology, Inc. | Common Stock | 0% | $0 | 0 | Deerfield Mgmt, L.P. | 31 Dec 2024 |
Schedules 13D/G Reported by James E. Flynn:
| Sym | Target | Class | Ownership | Change | Current Shares | Change | Value | Reporting name | Form | Report Period | Filing Date |
|---|
* An asterisk sign (*) next to the price indicates that the price is likely invalid.